CN103223018B - Flos Osmanthi Fragrantis polyphenol extract and its production and use - Google Patents
Flos Osmanthi Fragrantis polyphenol extract and its production and use Download PDFInfo
- Publication number
- CN103223018B CN103223018B CN201310169455.1A CN201310169455A CN103223018B CN 103223018 B CN103223018 B CN 103223018B CN 201310169455 A CN201310169455 A CN 201310169455A CN 103223018 B CN103223018 B CN 103223018B
- Authority
- CN
- China
- Prior art keywords
- osmanthus
- sweet
- extract
- polyphenols
- scented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000284 extract Substances 0.000 title claims abstract description 82
- 235000013824 polyphenols Nutrition 0.000 title claims abstract description 75
- 150000008442 polyphenolic compounds Chemical class 0.000 title claims abstract description 73
- 238000004519 manufacturing process Methods 0.000 title description 4
- 241000628997 Flos Species 0.000 title 1
- 241000333181 Osmanthus Species 0.000 claims abstract description 85
- 235000019082 Osmanthus Nutrition 0.000 claims abstract description 83
- 244000242564 Osmanthus fragrans Species 0.000 claims abstract description 41
- 235000019083 Osmanthus fragrans Nutrition 0.000 claims abstract description 41
- 238000000605 extraction Methods 0.000 claims abstract description 25
- 239000000706 filtrate Substances 0.000 claims abstract description 20
- 239000000047 product Substances 0.000 claims abstract description 18
- 239000007788 liquid Substances 0.000 claims abstract description 16
- 238000000874 microwave-assisted extraction Methods 0.000 claims abstract description 16
- 238000002360 preparation method Methods 0.000 claims abstract description 16
- 230000036541 health Effects 0.000 claims abstract description 12
- 239000003814 drug Substances 0.000 claims abstract description 10
- 239000007864 aqueous solution Substances 0.000 claims abstract description 8
- 230000000259 anti-tumor effect Effects 0.000 claims abstract description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 43
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 claims description 42
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 claims description 33
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 claims description 33
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 claims description 33
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 claims description 33
- 235000001368 chlorogenic acid Nutrition 0.000 claims description 33
- 229940074393 chlorogenic acid Drugs 0.000 claims description 33
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 claims description 33
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 claims description 33
- 239000000203 mixture Substances 0.000 claims description 27
- -1 phenylethanol glycoside Chemical class 0.000 claims description 26
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- KDSWDGKIENPKLB-QJDQKFITSA-N verbascoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC(=O)CCC=2C=C(O)C(O)=CC=2)[C@@H](CO)O[C@@H](OCCC=2C=C(O)C(O)=CC=2)[C@@H]1O KDSWDGKIENPKLB-QJDQKFITSA-N 0.000 claims description 24
- QFRYQWYZSQDFOS-UHFFFAOYSA-N verbascoside Natural products CC1OC(COC2C(O)C(COC3OC(C(O)C(O)C3O)C(=O)O)OC(Oc4cc(O)cc5OC(=CC(=O)c45)c6ccc(O)c(O)c6)C2O)C(O)C(O)C1O QFRYQWYZSQDFOS-UHFFFAOYSA-N 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 23
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 claims description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 21
- 235000004883 caffeic acid Nutrition 0.000 claims description 21
- 229940074360 caffeic acid Drugs 0.000 claims description 21
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 claims description 21
- 229930182470 glycoside Natural products 0.000 claims description 19
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-Phenylethanol Natural products OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 claims description 17
- 150000007965 phenolic acids Chemical class 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- 206010028980 Neoplasm Diseases 0.000 claims description 4
- 239000012065 filter cake Substances 0.000 claims description 4
- 206010060862 Prostate cancer Diseases 0.000 claims description 3
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 3
- 206010006187 Breast cancer Diseases 0.000 claims description 2
- 208000026310 Breast neoplasm Diseases 0.000 claims description 2
- 244000046052 Phaseolus vulgaris Species 0.000 claims 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 230000006837 decompression Effects 0.000 claims 1
- 238000004108 freeze drying Methods 0.000 claims 1
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 13
- 241000196324 Embryophyta Species 0.000 abstract description 7
- 238000002156 mixing Methods 0.000 abstract description 3
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 40
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 20
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 20
- 230000000052 comparative effect Effects 0.000 description 16
- 239000000843 powder Substances 0.000 description 16
- 238000004128 high performance liquid chromatography Methods 0.000 description 12
- 239000000523 sample Substances 0.000 description 11
- 239000000463 material Substances 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 150000002989 phenols Chemical class 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 6
- 238000004737 colorimetric analysis Methods 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 238000000120 microwave digestion Methods 0.000 description 6
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 6
- 239000004810 polytetrafluoroethylene Substances 0.000 description 6
- 238000002390 rotary evaporation Methods 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 235000009048 phenolic acids Nutrition 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000004663 cell proliferation Effects 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 238000007710 freezing Methods 0.000 description 4
- 230000008014 freezing Effects 0.000 description 4
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 210000004881 tumor cell Anatomy 0.000 description 4
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000010200 folin Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 229960003604 testosterone Drugs 0.000 description 3
- 239000002677 5-alpha reductase inhibitor Substances 0.000 description 2
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 2
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 2
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 2
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 102000001307 androgen receptors Human genes 0.000 description 2
- 108010080146 androgen receptors Proteins 0.000 description 2
- 229960003473 androstanolone Drugs 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 2
- 229960004039 finasteride Drugs 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 235000017807 phytochemicals Nutrition 0.000 description 2
- 229930000223 plant secondary metabolite Natural products 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 239000013558 reference substance Substances 0.000 description 2
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 2
- 238000009777 vacuum freeze-drying Methods 0.000 description 2
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 208000027877 Disorders of Sex Development Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020112 Hirsutism Diseases 0.000 description 1
- 241001495448 Impatiens <genus> Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- XJLXINKUBYWONI-NNYOXOHSSA-N NADP zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-N 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 201000005613 Pseudohermaphroditism Diseases 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 206010068168 androgenetic alopecia Diseases 0.000 description 1
- 201000002996 androgenic alopecia Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000011362 coarse particle Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229930190166 impatien Natural products 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 1
- 235000007743 myricetin Nutrition 0.000 description 1
- 229940116852 myricetin Drugs 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000006190 sub-lingual tablet Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
本发明涉及一种从桂花中提取的植物多酚类提取物及其制法和用途。具体而言,本发明公开了一种桂花多酚提取物的制备方法,包括以下步骤:1)、将桂花与提取剂水溶液按照1g/15~60ml的料液比混合后于200~500KPa的压力下,80~200W功率进行微波提取,提取时间为3~20min;重复上述提取;2)、所得滤液合并后进行干燥处理,得桂花多酚提取物。该桂花多酚提取物,可用于制备抗肿瘤的药物或保健品,也可用于抑制5α-还原酶活性。
The invention relates to a plant polyphenol extract extracted from osmanthus fragrans and its preparation method and application. Specifically, the present invention discloses a preparation method of sweet-scented osmanthus polyphenols extract, comprising the following steps: 1) Mixing sweet-scented osmanthus and extractant aqueous solution according to the solid-liquid ratio of 1g/15-60ml, and then mixing them under a pressure of 200-500KPa Under 80~200W power, microwave extraction is carried out, and the extraction time is 3~20min; repeat the above extraction; 2), the obtained filtrates are combined and then dried to obtain the osmanthus polyphenols extract. The sweet-scented osmanthus polyphenol extract can be used to prepare anti-tumor medicine or health product, and can also be used to inhibit the activity of 5α-reductase.
Description
技术领域 technical field
本发明涉及农副产品深加工及综合利用领域。更具体地涉及一种从桂花中提取的植物多酚类提取物及其制法和用途。The invention relates to the field of deep processing and comprehensive utilization of agricultural and sideline products. More specifically, it relates to a plant polyphenol extract extracted from osmanthus fragrans and its preparation method and application.
背景技术 Background technique
桂花 Osmanthus fragrans Lour. 又名木犀、九里香、金粟,是我国十大传统名花之一,既是著名的香料植物,也是优良的园林绿化树种,兼有良好的生态效益、 社会效益和经济效益。桂花在我国栽培历史悠久,在四川、 云南、 浙江、 广西、湖北等省区均有野生;淮河流域至黄河下游以南各地普遍地栽,以北则以盆栽居多。全世界约有桂花品种40 种,我国有27种,是桂花的主要分布中心,种质资源极其丰富。Osmanthus fragrans Lour. Also known as sweet-scented osmanthus, jiulixiang, and golden millet, it is one of the top ten traditional famous flowers in my country. It is not only a famous spice plant, but also an excellent landscaping tree species, with good ecological, social and economic benefits. . Osmanthus fragrans has a long history of cultivation in my country, and it is wild in Sichuan, Yunnan, Zhejiang, Guangxi, Hubei and other provinces and regions; it is widely planted from the Huaihe River Basin to the south of the lower reaches of the Yellow River, and potted plants are mostly used in the north. There are about 40 species of sweet-scented osmanthus in the world, and 27 species in my country. It is the main distribution center of sweet-scented osmanthus, and its germplasm resources are extremely rich.
桂花是传统的香花植物,花虽小,但香味持久稳定。我国拥有悠久的食用桂花传统,早在2000年前,就用桂花制酒、制花茶,近年来随着桂花种植面积的不断扩大以及食品工业的迅速发展,桂花糕、桂花酱等产品也得到大规模生产。Osmanthus fragrans is a traditional fragrant flower plant. Although the flowers are small, the fragrance is long-lasting and stable. my country has a long tradition of edible osmanthus. As early as 2000 years ago, osmanthus was used to make wine and scented tea. In recent years, with the continuous expansion of osmanthus planting area and the rapid development of food industry, osmanthus cake, osmanthus sauce and other products have also been widely used mass production.
桂花含有丰富的营养物质。桂花中总氨基酸含量高达13.78%,其中人体必需氨基酸为6.26%,占氨基酸总量的45.55%,且氨基酸的配比合理,是一种优质蛋白质。此外桂花含有丰富的维生素、胡萝卜素和各种微量元素,钾、铁、锌。关于桂花次级代谢产物的研究,主要集中在其精油提取与芳香成分分析。Li-mei Wang等(2009)考察了不同开花期桂花的精油成分差异,发现桂花精油中含有多种包括芳樟醇及其氧化物、α-紫罗兰酮、β-紫罗兰酮、橙花醇等20余种有效成分。Chun-Di Hu 等(2010)更进一步发现桂花精油含有高达73种成分。在其他生物活性物质方面研究较少。Chien-Ya Hung等(2012)对桂花中酚类成分进行了分离鉴定,发现其含有芦丁、毛蕊花苷等5种酚类化合物。桂花具有抗氧化、抗炎等生物活性,并且在神经保护、抑制黑色素形成方面表现出一定的效果,但其功效与成分之间的联系少有研究。Osmanthus is rich in nutrients. The total amino acid content in osmanthus is as high as 13.78%, of which the essential amino acid for human body is 6.26%, accounting for 45.55% of the total amino acid, and the ratio of amino acid is reasonable, it is a high-quality protein. In addition, osmanthus is rich in vitamins, carotene and various trace elements, potassium, iron and zinc. The research on secondary metabolites of osmanthus fragrans mainly focuses on the extraction of essential oil and analysis of aromatic components. Li-mei Wang et al. (2009) investigated the differences in essential oil components of osmanthus fragrans at different flowering stages, and found that osmanthus osmanthus essential oil contains a variety of linalool and its oxides, α-ionone, β-ionone, nerol, etc. 20 remaining active ingredients. Chun-Di Hu et al. (2010) further found that osmanthus essential oil contains up to 73 components. Less research has been done on other biologically active substances. Chien-Ya Hung et al. (2012) isolated and identified phenolic components in osmanthus, and found that it contained 5 kinds of phenolic compounds such as rutin and verbascoside. Osmanthus fragrans has biological activities such as anti-oxidation and anti-inflammation, and has shown certain effects in neuroprotection and inhibition of melanin formation, but there is little research on the relationship between its efficacy and components.
微波提取实际上主要是微波对提取溶剂及样品的加热作用。微波加热有两种机理,即离子传导和偶极子转动,该原理使微波可产生瞬间高温,因此提取时间短;微波在传输过程中,遇到不同物料时,会产生反射、吸收和穿透现象。当微波能穿透介质时,即微波对样品内部直接加热,这样避免发生传统加热方式从单一部位加热的问题,因而使微波加热具有加热均匀的优点。同时,由于物料所组成的各个部分的介电性质往往不同,微波就对这种物料呈现出选择加热的特性。高压微波辅助提取是在密闭提取罐中进行,其内部压力可达 1MPa 以上,因此溶剂沸点比常压下的溶剂沸点提高了许多,从而使微波提取可以达到常压下使用同样溶剂所达不到的提取温度,既可以提高提取效率又不致于分解待测提取物。Microwave extraction is actually mainly the heating effect of microwave on the extraction solvent and sample. Microwave heating has two mechanisms, namely ion conduction and dipole rotation. This principle enables microwaves to generate instantaneous high temperature, so the extraction time is short; microwaves will reflect, absorb and penetrate when encountering different materials during transmission. Phenomenon. When the microwave can penetrate the medium, that is, the microwave directly heats the inside of the sample, which avoids the problem of heating from a single part in the traditional heating method, so that the microwave heating has the advantage of uniform heating. At the same time, because the dielectric properties of each part of the material are often different, microwaves have the characteristic of selective heating of this material. High-pressure microwave-assisted extraction is carried out in a closed extraction tank, and its internal pressure can reach more than 1MPa, so the boiling point of the solvent is much higher than that of the solvent under normal pressure, so that the microwave extraction can reach the same solvent under normal pressure. The extraction temperature can improve the extraction efficiency without decomposing the extract to be tested.
据WHO国际肿瘤研究理事会 (IARC)负责人报道,到2020年全球肿瘤发病率将上升50%,到每年1500万。恶性肿瘤的临床治疗方法迄今已经发展多种如手术切除、化疗、放疗等,但是这些治疗方法在杀死肿瘤细胞的同时,也会对正常机体造成极大的损害,副作用很大。通过天然活性物质辅助作用,减少临床用药剂量或手术强度,具有重大的研究意义。针对桂花有效成分及其生物活性研究的局限性,拓展桂花有效成分的研究,并将其应用于肿瘤的防治,具有重大的开发意义。According to the head of the WHO International Cancer Research Council (IARC), the global cancer incidence rate will increase by 50% to 15 million per year by 2020. The clinical treatment methods for malignant tumors have been developed so far, such as surgical resection, chemotherapy, radiotherapy, etc., but these treatment methods will cause great damage to the normal body while killing tumor cells, with great side effects. It is of great research significance to reduce the dosage of clinical medication or the intensity of surgery through the auxiliary effect of natural active substances. In view of the limitations of the research on the active ingredients of osmanthus fragrans and their biological activities, it is of great significance to expand the research on the active ingredients of osmanthus fragrans and apply them to the prevention and treatment of tumors.
5α-还原酶(5α-reductase)是依赖还原性辅酶Ⅱ(NADPH)的膜蛋白酶,它能催化睾酮(T)转化为二氢睾酮(DHT),T和DHT作用于同一种雄激素受体,但DHT的催化活性更强,对雄激素受体有较强的亲和力,所以5α-还原酶的催化转化作用能够放大雄激素反应,进而可能引起假两性畸形、痤疮、雄激素源性脱发、女性多毛症等症状,同时与前列腺增生甚至前列腺癌的发生也密不可分,因此寻找高效5α-还原酶抑制剂具有重要的意义。研究者发现某些植物化学素如杨梅素、黄檀酚、凤仙花提取物等(Matsuda H, 2001; Shirota O, 2003; Ishiguro K, 2000.)具有一定程度的5α-还原酶抑制活性,国内常用的治疗前列腺增生的中成药前列康的主要活性成分之一也被证明是油菜花粉中的一种多聚醚,研究提示天然植物化学素是作为5α-还原酶抑制剂的优质来源。5α-reductase (5α-reductase) is a membrane protease dependent on reducing coenzyme II (NADPH), which can catalyze the conversion of testosterone (T) into dihydrotestosterone (DHT). T and DHT act on the same androgen receptor, However, the catalytic activity of DHT is stronger and has a stronger affinity for the androgen receptor, so the catalytic transformation of 5α-reductase can amplify the androgen response, which may cause pseudohermaphroditism, acne, androgenetic alopecia, female Symptoms such as hirsutism are also inseparable from the occurrence of benign prostatic hyperplasia and even prostate cancer, so it is of great significance to find high-efficiency 5α-reductase inhibitors. Researchers have found that certain phytochemicals such as myricetin, dalbergol, and impatiens extract (Matsuda H, 2001; Shirota O, 2003; Ishiguro K, 2000.) have a certain degree of 5α-reductase inhibitory activity, One of the main active ingredients of Qianliekang, a Chinese patent medicine commonly used in the treatment of benign prostatic hyperplasia, has also been proved to be a polyether in rapeseed pollen. Studies have shown that natural phytochemicals are high-quality sources of 5α-reductase inhibitors.
发明内容 Contents of the invention
本发明要解决的技术问题是提供一种桂花多酚提取物及其制备方法和用途。The technical problem to be solved by the present invention is to provide an osmanthus fragrans polyphenol extract and its preparation method and application.
为了解决上述技术问题,本发明提供一种桂花多酚提取物的制备方法,包括步骤:In order to solve the problems of the technologies described above, the invention provides a preparation method of sweet-scented osmanthus polyphenols extract, comprising steps:
1)、采用高压微波提取法:1), using high-pressure microwave extraction method:
将桂花与提取剂水溶液按照1g/15~60ml的料液比混合后于200~500KPa的压力下,80~200W功率进行微波提取,提取时间为3~ 20min;过滤,得滤饼和首次滤液;After mixing osmanthus fragrans and extractant aqueous solution according to the solid-liquid ratio of 1g/15~60ml, under the pressure of 200~500KPa, the power of 80~200W is used for microwave extraction, and the extraction time is 3~20min; filter to obtain filter cake and first filtrate;
以滤饼替代桂花重复上述微波提取和过滤至少一次,得再次滤液;Replace the sweet-scented osmanthus with the filter cake and repeat the above microwave extraction and filtration at least once to obtain the filtrate again;
所述提取剂水溶液中提取剂的体积浓度为70%~90%;The volume concentration of the extractant in the aqueous extractant solution is 70% to 90%;
2)、将步骤1)所得的首次滤液和再次滤液合并后进行干燥处理,得桂花多酚提取物。2) Combine the first filtrate and the second filtrate obtained in step 1) and dry them to obtain the osmanthus fragrans polyphenols extract.
作为本发明的桂花多酚提取物的制备方法的改进:提取剂为丙酮、甲醇或乙醇。As the improvement of the preparation method of the sweet-scented osmanthus polyphenol extract of the present invention: the extractant is acetone, methanol or ethanol.
作为本发明的桂花多酚提取物的制备方法的进一步改进:步骤2)中的干燥为减压干燥、冷冻干燥、薄膜干燥中的至少一种。As a further improvement of the preparation method of the osmanthus fragrans polyphenol extract of the present invention: the drying in step 2) is at least one of vacuum drying, freeze drying, and film drying.
作为本发明的桂花多酚提取物的制备方法的进一步改进:步骤1)中微波提取压力为300~450KPa,功率为80~120W。As a further improvement of the preparation method of the sweet-scented osmanthus polyphenol extract of the present invention: in step 1), the microwave extraction pressure is 300-450KPa, and the power is 80-120W.
作为本发明的桂花多酚提取物的制备方法的进一步改进:提取剂水溶液为体积浓度80%的丙酮水溶液,料液比1 g/45ml,压力为300KPa,100W 微波提取3min。As a further improvement of the preparation method of the sweet-scented osmanthus polyphenols extract of the present invention: the aqueous extractant solution is an aqueous acetone solution with a volume concentration of 80%, a solid-liquid ratio of 1 g/45ml, a pressure of 300KPa, and 100W microwave extraction for 3min.
本发明还同时提供了上述方法制备而得桂花多酚提取物:该桂花多酚提取物中总酚重量含量为30%~70%。The present invention also provides an osmanthus fragrans polyphenol extract prepared by the above method at the same time: the total phenol weight content in the osmanthus fragrans polyphenols extract is 30%-70%.
作为本发明的桂花多酚提取物的改进:总酚中,酚酸的重量含量为0.5%~2%,苯乙醇苷的重量含量为50%~80%。As an improvement of the osmanthus fragrans polyphenol extract of the present invention: in the total phenols, the weight content of phenolic acid is 0.5%-2%, and the weight content of phenylethanol glycoside is 50%-80%.
作为本发明的桂花多酚提取物的进一步改进:酚酸中,绿原酸的重量含量为40%~70%,绿原酸、咖啡酸及对香豆酸的质量比为25~50:5~15:6~10;苯乙醇苷中,毛蕊花苷的重量含量为80%~95%。As a further improvement of the osmanthus polyphenols extract of the present invention: in the phenolic acids, the weight content of chlorogenic acid is 40% ~ 70%, and the mass ratio of chlorogenic acid, caffeic acid and p-coumaric acid is 25 ~ 50:5 ~15: 6~10; among the phenylethanol glycosides, the weight content of verbascoside is 80%~95%.
备注说明:本发明所述的酚酸包含绿原酸、咖啡酸和对香豆酸,所述的苯乙醇苷包括毛蕊花苷。Remarks: The phenolic acids described in the present invention include chlorogenic acid, caffeic acid and p-coumaric acid, and the phenylethanol glycosides include verbascoside.
本发明还同时提供了上述方法制备而得的桂花多酚提取物的用途,在制备用于抗肿瘤的药物或保健品中的应用。The present invention also provides the use of the sweet-scented osmanthus polyphenol extract prepared by the above method, and its application in the preparation of antitumor drugs or health care products.
本发明还同时提供了上述方法制备而得的桂花多酚提取物的另一种用途,用于抑制5α-还原酶活性(即,在制备5α-还原酶活性抑制剂中的应用)。The present invention also provides another use of the sweet-scented osmanthus polyphenols extract prepared by the above method, for inhibiting 5α-reductase activity (that is, the application in the preparation of 5α-reductase activity inhibitors).
本发明的桂花多酚提取物可制成组合物,该组合物中含有0.01wt%~99.9wt%(更佳的,0.1 wt %-90wt%)本发明所述的桂花多酚提取物,以及含有可接受的载体(包括药品、食品或化妆品中可接受的载体)。The sweet-scented osmanthus polyphenol extract of the present invention can be made into composition, contains 0.01wt%~99.9wt% (better, 0.1wt%-90wt%) sweet-scented osmanthus polyphenol extract of the present invention in the composition, and Contains acceptable carriers (including those acceptable in pharmaceuticals, food or cosmetics).
本发明人经过深入研究,对桂花有效成分进行了提取分离,获得了一种可有效抗癌的多酚提取物---桂花多酚提取物,对该提取物的研究表明,该提取物主要含绿原酸、咖啡酸、对香豆酸以及毛蕊花苷等成分。After in-depth research, the inventor extracted and separated the active ingredients of osmanthus fragrans, and obtained a polyphenol extract that can effectively fight cancer --- osmanthus fragrans polyphenols extract. Research on the extract shows that the extract mainly Contains chlorogenic acid, caffeic acid, p-coumaric acid and verbascoside.
如本文所用,桂花是指木犀科木犀属植物桂花的花。可作为本发明原料的桂花可以是桂花鲜花、桂花干花、桂花茶及以桂花为原料的其他产品或经蒸馏提取后的桂花残渣。优选原料是桂花鲜花、桂花干花。As used herein, sweet-scented osmanthus refers to the flower of sweet-scented osmanthus, a plant of the genus Osmanthus in the family Oleaceae. The osmanthus fragrans that can be used as the raw material of the present invention can be osmanthus fragrans fresh flowers, osmanthus fragrans dried flowers, osmanthus fragrans tea and other products using osmanthus fragrans as raw materials or residues of osmanthus fragrans after distillation extraction. The preferred raw materials are osmanthus fresh flowers and dried osmanthus flowers.
本发明采用的原料可以进行预处理,也可以不经过预处理。一种优选原料是粉末形式的桂花。例如,收集新鲜桂花或添加桂花的其他产品,干燥至水分含量(重量)10%以下,粉碎至约20~40目的粉末。The raw materials used in the present invention may or may not be pretreated. A preferred raw material is sweet osmanthus in powder form. For example, collect fresh sweet-scented osmanthus or other products added with sweet-scented osmanthus, dry to a moisture content (weight) below 10%, and pulverize to about 20-40 mesh powder.
可用于本发明的桂花品种和产地没有特别限制,可以是不同品种的桂花,如金桂、银桂等,也可以来自不同产地如广西、浙江等。优选香味浓郁的金桂花。The osmanthus species that can be used in the present invention and the place of production are not particularly limited, and can be osmanthus of different varieties, such as golden osmanthus, silver osmanthus, etc., and can also come from different places of production such as Guangxi, Zhejiang, etc. The fragrant golden osmanthus is preferred.
本发明的桂花多酚提取物宜采用高压微波技术提取,虽然也可用其他方法提取。The sweet-scented osmanthus polyphenols extract of the present invention should be extracted by high-pressure microwave technology, although it can also be extracted by other methods.
一种优选的方法是采用高压微波提取技术从桂花及其相关产品中或桂花渣提取多酚类化合物。在一优选例中,提取剂为80%(体积浓度)丙酮,提取压力为200~500KPa,料液比1:15~1:60(g/ml),微波提取3~20min。A preferred method is to extract polyphenolic compounds from sweet-scented osmanthus and its related products or residues of sweet-scented osmanthus by using high-pressure microwave extraction technology. In a preferred example, the extractant is 80% (volume concentration) acetone, the extraction pressure is 200-500KPa, the solid-liquid ratio is 1:15-1:60 (g/ml), and the microwave extraction is 3-20min.
在更优选例中,将约20-40目桂花粉末(水分重量含量≤10%)加入于智能微波消解仪的聚四氟乙烯材料制成的内杯中,提取剂选用80%(体积浓度)丙酮,料液比1:15-1:45(g/ml),控制压力200~500KPa,80~200W 微波处理 3~20min,离心,重复提取2次以上,过滤合并上清液(即,滤液),上清液经真空旋转蒸发浓缩,低温干燥后得桂花多酚提取物。In a more preferred example, about 20-40 mesh osmanthus powder (moisture weight content ≤ 10%) is added to the inner cup made of polytetrafluoroethylene material of the intelligent microwave digestion instrument, and the extractant is selected as 80% (volume concentration) Acetone, solid-liquid ratio 1:15-1:45 (g/ml), control pressure 200-500KPa, 80-200W microwave treatment for 3-20min, centrifuge, repeat extraction more than 2 times, filter and combine supernatant (i.e., filtrate ), the supernatant was concentrated by vacuum rotary evaporation, and dried at low temperature to obtain osmanthus polyphenols extract.
本发明的桂花多酚提取物是一种以毛蕊花苷为主的多酚混合物。用福林酚法检测,以绿原酸为标准品,测得桂花多酚提取物中总酚含量为30%~70%,更佳的40%~60%;用紫外分光光度法测定总酚中苯乙醇苷质量分数为50%~80%,更佳的60%~75%;用HPLC分析酚酸及苯乙醇苷的组成,其中酚酸中绿原酸含量为40%~70%,更佳的45%~65%,绿原酸、咖啡酸及对香豆酸质量比为25~50:5~15:6~10,更佳的25~45:5~12:7~9,苯乙醇苷中毛蕊花苷含量为80%~95%,更佳的82%~92%。The osmanthus polyphenol extract of the present invention is a polyphenol mixture mainly composed of verbascoside. Detect with Folin's phenol method, take chlorogenic acid as standard substance, measure total phenolic content in sweet-scented osmanthus polyphenols extract to be 30%~70%, better 40%~60%; The mass fraction of phenylethanol glycosides is 50% to 80%, more preferably 60% to 75%; the composition of phenolic acids and phenylethanol glycosides is analyzed by HPLC, wherein the content of chlorogenic acid in phenolic acids is 40% to 70%, more preferably The best 45%~65%, the mass ratio of chlorogenic acid, caffeic acid and p-coumaric acid is 25~50:5~15:6~10, more preferably 25~45:5~12:7~9, benzene The content of verbascoside in ethanol glycosides is 80%-95%, more preferably 82%-92%.
本发明的桂花多酚提取物具有抗肿瘤及抑制5α-还原酶活力的生物活性,因此可用于制备抗肿瘤或具有5α-还原酶抑制作用的药物、保健品和食品。因此,本发明还提供了一种含有桂花多酚提取物作为有效成份的组合物(包括药物组合物、保健品组合物、食品组合物和化妆品组合物等),这些组合物可用于预防、治疗或辅助治疗肿瘤细胞增殖。The sweet-scented osmanthus polyphenol extract of the invention has the biological activity of anti-tumor and inhibition of 5α-reductase activity, so it can be used to prepare anti-tumor or 5α-reductase inhibitory medicines, health care products and food. Therefore, the present invention also provides a composition (comprising pharmaceutical composition, health product composition, food composition and cosmetic composition etc.) Or adjuvant therapy for tumor cell proliferation.
在获得桂花多酚提取物后,可用常规方法将其与药学上、食品学上或保健品或化妆品上可接受的载体、赋形剂或稀释剂相混合,形成本发明的药物组合物、食品组合物或保健品组合物。这类载体包括(但并不限于):盐水、缓冲液、葡萄糖、水、甘油、乙醇、及其组合。After obtaining the sweet osmanthus polyphenols extract, it can be mixed with pharmaceutically, food science or health care products or cosmetically acceptable carriers, excipients or diluents by conventional methods to form the pharmaceutical composition of the present invention, food Composition or health product composition. Such carriers include, but are not limited to: saline, buffer, dextrose, water, glycerol, ethanol, and combinations thereof.
以药物组合物或保健品组合物为例,它们可以为固态(如颗粒剂、片剂、冻干粉、栓剂、胶囊、舌下含片)或液态(如口服液)或其他合适的形状。本发明桂花多酚提取物的含量通常为组合物重量的1%~99%,较佳地为2%~96%,更佳地为5%~90%,最佳地15%~80%。Taking pharmaceutical compositions or health product compositions as examples, they can be in solid state (such as granules, tablets, freeze-dried powder, suppositories, capsules, sublingual tablets) or liquid (such as oral liquid) or other suitable shapes. The content of the osmanthus fragrans polyphenols extract of the present invention is usually 1%-99% by weight of the composition, preferably 2%-96%, more preferably 5%-90%, most preferably 15%-80%.
保健品组合物可以为单剂或多剂形式。按施用剂量计,通常含有10~2000mg/剂,较佳地约20~1000mg/剂,更佳地50~500mg/剂。Nutraceutical compositions can be in single or multi-dose form. According to the administration dose, it usually contains 10-2000 mg/dose, preferably about 20-1000 mg/dose, more preferably 50-500 mg/dose.
本发明的保健品组合物可以通过常规途径进行给药,优选方式是口服。药物制剂应与给药方式相匹配。本发明保健品的施用量,按活性物质计算,通常为每天约桂花多酚提取物0.1~500mg /kg体重,较佳地约0.5~50mg/kg体重。此外,本发明的制剂还可与其他辅助制剂一起使用,例如,其他辅助制剂包括各种现有的抗癌活性物质或抗氧化活性物质。The health product composition of the present invention can be administered through conventional routes, preferably orally. The pharmaceutical formulation should match the mode of administration. The application amount of the health care product of the present invention, calculated by active substance, is usually about 0.1-500 mg/kg body weight of osmanthus fragrans polyphenols extract per day, preferably about 0.5-50 mg/kg body weight. In addition, the preparations according to the invention can also be used together with other auxiliary preparations, for example, including various existing anticancer active substances or antioxidative active substances.
本发明具有如下优点:The present invention has the following advantages:
(a)提供了一种来源广阔、组成明晰、品质优良、质量可控、用途广泛并具有多种生理和药理活性的桂花多酚提取物。(a) Provide an osmanthus fragrans polyphenol extract with broad sources, clear composition, high quality, controllable quality, wide application and various physiological and pharmacological activities.
(b)通过高压微波提取技术实现了桂花及其相关产品中多酚的高效提取,操作工艺简便。(b) The efficient extraction of polyphenols in Osmanthus fragrans and its related products was realized by high-pressure microwave extraction technology, and the operation process is simple.
综上所述,多酚是含有多元酚羟基的一类化合物,在自然界分布极为广泛。植物多酚种类繁多,主要包括酚酸、黄酮等,研究表明具有清除自由基、抗氧化、缓解动脉粥样硬化抗菌剂抗肿瘤等多种生理活性。食用花卉中含有大量多酚类物质,而桂花作为常见的食用花卉之一,品种丰富,开发潜力大,因此从桂花中得到多酚提取物并拓展其保健功能具有重要开发意义。To sum up, polyphenols are a class of compounds containing polyhydric phenolic hydroxyl groups, which are widely distributed in nature. There are many kinds of plant polyphenols, mainly including phenolic acids, flavonoids, etc. Studies have shown that they have various physiological activities such as scavenging free radicals, anti-oxidation, alleviating atherosclerosis, antibacterial agents, and anti-tumor. Edible flowers contain a large amount of polyphenols, and as one of the common edible flowers, osmanthus is rich in varieties and has great potential for development. Therefore, it is of great significance to obtain polyphenol extracts from osmanthus and expand its health care functions.
本发明通过超声波辅助提取技术实现了桂花及其相关产品中多酚的高效提取,操作工艺简便,且发现该提取物具有良好的抗癌功效,在食品、保健品、药品中有广泛的应用前景。The present invention realizes the high-efficiency extraction of polyphenols in sweet-scented osmanthus and its related products through ultrasonic-assisted extraction technology, the operation process is simple, and it is found that the extract has good anti-cancer effects, and has wide application prospects in food, health care products and medicines .
附图说明 Description of drawings
下面结合附图对本发明的具体实施方式作进一步详细说明。The specific implementation manners of the present invention will be described in further detail below in conjunction with the accompanying drawings.
图1是绿原酸、咖啡酸、对香豆酸和毛蕊花苷对照品及桂花样品HPLC分离结果图谱,图谱显示,1、10.1min左右为绿原酸,2、12.8min左右为咖啡酸,3、19.3min左右为对香豆酸,4、30.7min左右为毛蕊花苷。Figure 1 is the spectrum of HPLC separation results of chlorogenic acid, caffeic acid, p-coumaric acid and verbascoside reference substance and sweet-scented osmanthus sample. The spectrum shows that 1 and 10.1min are chlorogenic acid, 2 and 12.8min are caffeic acid, and 3 , 19.3min for p-coumaric acid, 4, 30.7min for verbascoside.
图2是桂花桂花多酚提取物HPLC分离结果图谱,其中B图为A图中8-22min放大效果图。与对照品图谱对应,1、10.1min左右为绿原酸,2、12.8min左右为咖啡酸,3、19.3min左右为对香豆酸,4、30.7min左右为毛蕊花苷;Fig. 2 is the HPLC separation result spectrum of osmanthus osmanthus polyphenols extract, wherein B is the 8-22min enlarged effect diagram in A. Corresponding to the spectrum of the reference substance, about 1 and 10.1 minutes are chlorogenic acid, about 2 and 12.8 minutes are caffeic acid, about 3 and 19.3 minutes are p-coumaric acid, and about 4 and 30.7 minutes are verbascoside;
图3分别为绿原酸、咖啡酸、对香豆酸和毛蕊花苷的结构图。Figure 3 is the structural diagrams of chlorogenic acid, caffeic acid, p-coumaric acid and verbascoside, respectively.
具体实施方式 Detailed ways
下面结合具体实施例,进一步阐述本发明。应理解,这些实施例仅用于说明本发明而不用于限制本发明的范围。下列实施例中未注明具体条件的实验方法,通常按照常规条件,或按照制造厂商所建议的条件。Below in conjunction with specific embodiment, further illustrate the present invention. It should be understood that these examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention. For the experimental methods without specific conditions indicated in the following examples, the conventional conditions or the conditions suggested by the manufacturer are usually followed.
检测通用方法为:The general method of detection is:
1)、桂花多酚提取物中总酚含量测定—— 福林酚法1) Determination of total phenol content in osmanthus polyphenols extract - Folin phenol method
以绿原酸为对照,采用福林酚法测定总酚。取500ul样品(稀释一定倍数,即每ml样品中含有2mg的桂花多酚提取物)或标准液(浓度为10-150μg/ml的绿原酸甲醇溶液),添加50ul 2M的福林酚,混匀反应5-8min,加入1ml 1M的NaOH,用水定容至6ml,常温反应90min后760nm波长测定吸光度,并计算总酚的绿原酸当量浓度。With chlorogenic acid as the control, total phenols were determined by Folin's phenol method. Take 500ul sample (diluted to a certain multiple, that is, each ml sample contains 2mg of osmanthus polyphenol extract) or standard solution (chlorogenic acid methanol solution with a concentration of 10-150μg/ml), add 50ul 2M folinol, mix Evenly react for 5-8 minutes, add 1ml of 1M NaOH, dilute to 6ml with water, react at room temperature for 90 minutes, measure the absorbance at 760nm wavelength, and calculate the chlorogenic acid equivalent concentration of total phenols.
2)、桂花多酚提取物种苯乙醇苷含量测定——紫外分光光度法2) Determination of the content of phenylethanol glycosides in osmanthus polyphenols extracts——UV spectrophotometry
以毛蕊花苷为对照,采用紫外分光光度法测定总乙醇苷。将一定量样品(每ml样品中含有8mg的桂花多酚提取物)通过D-101大孔树脂吸附依次用样品体积25倍的水及20%(v/v)乙醇洗脱,弃去洗脱液,后以50倍体积70%乙醇(v/v)洗脱,搜集洗脱液,蒸干,甲醇定容。330nm波长下测定吸光度,并计算毛蕊花苷当量浓度。Using verbascoside as a control, the total ethanol glycosides were determined by UV spectrophotometry. A certain amount of sample (containing 8 mg of osmanthus polyphenols extract per ml sample) was adsorbed by D-101 macroporous resin and eluted successively with water 25 times the sample volume and 20% (v/v) ethanol, and discarded. solution, and then eluted with 50 times the volume of 70% ethanol (v/v), collected the eluate, evaporated to dryness, and constant volume with methanol. The absorbance was measured at a wavelength of 330nm, and the equivalent concentration of verbascoside was calculated.
3)、桂花多酚提取物的有效成分分析——高效液相色谱法(HPLC)3) Analysis of active components of osmanthus polyphenols extract - high performance liquid chromatography (HPLC)
通过HPLC分离法对桂花多酚提取物进行成分分离和分析。The components of osmanthus fragrans polyphenols extract were separated and analyzed by HPLC separation method.
HPLC分离方法:采用Phenomenex Synergi 4μ hydro-RP 80A(250*4.6mm)色谱柱;流动相:A(乙酸水溶液,pH2.74)、B(乙腈),柱温38℃,流速0.8ml/min;在200~600nm之间进行紫外扫描,梯度洗脱程序如下:HPLC separation method: use Phenomenex Synergi 4μ hydro-RP 80A (250*4.6mm) chromatographic column; mobile phase: A (acetic acid aqueous solution, pH2.74), B (acetonitrile), column temperature 38 ℃, flow rate 0.8ml/min; Ultraviolet scanning was performed between 200-600nm, and the gradient elution procedure was as follows:
表1 梯度洗脱程序Table 1 Gradient elution program
以下实施例中所述的桂花粉末是指新鲜桂花干燥至水分含量(重量)10%以下,粉碎至约20~40目所得的粉末,重量为100g。The sweet-scented osmanthus powder described in the following examples refers to the powder obtained by drying fresh sweet-scented osmanthus to a water content (weight) below 10% and pulverizing to about 20-40 meshes, with a weight of 100 g.
实施例1、Embodiment 1,
将约20-40目桂花粉末加入智能微波消解仪的聚四氟乙烯材料制成的内杯中,提取剂选用80%丙酮(即体积浓度为80%的丙酮水溶液),料液比1:15(g/ml),控制压力200KPa,80W 微波处理 3min,过滤,再重复提取2次(即,以滤渣替代桂花粉末,依次重复上述微波处理和过滤2次),合并3次提取所得的滤液,滤液45℃真空旋转蒸发浓缩,浓缩液经-80℃预冻后真空冷冻干燥至恒重,得桂花多酚提取物,得率为15.1%。Add about 20-40 mesh sweet-scented osmanthus powder into the inner cup made of polytetrafluoroethylene material of the intelligent microwave digestion instrument. The extractant is 80% acetone (that is, the acetone aqueous solution with a volume concentration of 80%), and the ratio of solid to liquid is 1:15 (g/ml), control the pressure 200KPa, 80W microwave treatment for 3min, filter, and repeat the extraction twice (that is, replace the sweet-scented osmanthus powder with the filter residue, repeat the above microwave treatment and filtration twice in turn), combine the filtrate obtained from the three extractions, The filtrate was concentrated by vacuum rotary evaporation at 45°C, and the concentrated solution was pre-frozen at -80°C and vacuum freeze-dried to constant weight to obtain the polyphenol extract of osmanthus fragrans with a yield of 15.1%.
对提取物进行成分测定及分析,结果如图1、2所示。图1、2表明,该提取物含有绿原酸、咖啡酸、对香豆酸和毛蕊花苷。比色法与HPLC法分析桂花多酚提取物的成分含量,其总酚含量为30.5±1.3%。总酚中,绿原酸含量为0.25±0.01%,绿原酸、咖啡酸及对香豆酸质量比为30:5:6;苯乙醇苷含量为65.2±3.2%,苯乙醇苷中毛蕊花苷含量为87.6±1.1%。The components of the extract were determined and analyzed, and the results are shown in Figures 1 and 2. Figures 1 and 2 show that the extract contains chlorogenic acid, caffeic acid, p-coumaric acid and verbascoside. Colorimetric method and HPLC method were used to analyze the composition content of osmanthus fragrans polyphenols extract, and the total phenol content was 30.5±1.3%. Among the total phenols, the content of chlorogenic acid is 0.25±0.01%, the mass ratio of chlorogenic acid, caffeic acid and p-coumaric acid is 30:5:6; the content of phenylethanol glycoside is 65.2±3.2%, and verbascoside in phenylethanol glycoside The content is 87.6±1.1%.
实施例2、Embodiment 2,
将约20-40目桂花粉末加入智能微波消解仪的聚四氟乙烯材料制成的内杯中,提取剂选用80%丙酮,料液比1:25(g/ml),控制压力200KPa,80W 微波处理 5min,过滤,再重复提取2次(即,以滤渣替代桂花粉末,依次重复上述微波处理和过滤2次),合并3次提取所得的滤液,滤液45℃真空旋转蒸发浓缩,浓缩液经-80℃预冻后真空冷冻干燥至恒重,得桂花多酚提取物,得率为23.5%。Add about 20-40 mesh osmanthus powder into the inner cup made of polytetrafluoroethylene material of the intelligent microwave digestion instrument, use 80% acetone as the extractant, the ratio of solid to liquid is 1:25 (g/ml), and the control pressure is 200KPa, 80W Microwave treatment for 5 minutes, filter, and then repeat the extraction twice (that is, replace the osmanthus powder with the filter residue, repeat the above microwave treatment and filtration twice in turn), combine the filtrates obtained from the three extractions, and concentrate the filtrate by vacuum rotary evaporation at 45 °C. After pre-freezing at -80°C, vacuum freeze-dry to constant weight to obtain osmanthus polyphenols extract with a yield of 23.5%.
对提取物进行成分测定及分析,该提取物含有绿原酸、咖啡酸、对香豆酸和毛蕊花苷。比色法与HPLC法分析桂花多酚提取物的成分含量,其总酚含量为59.7±1.1%。总酚中,绿原酸含量为0.4±0.015%,绿原酸、咖啡酸及对香豆酸质量比为35:15:6;苯乙醇苷含量为71.5±1.9%,苯乙醇苷中毛蕊花苷含量为85.7±2.3%。Composition determination and analysis were carried out on the extract, which contained chlorogenic acid, caffeic acid, p-coumaric acid and verbascoside. Colorimetric method and HPLC method were used to analyze the composition content of osmanthus fragrans polyphenols extract, and the total phenol content was 59.7±1.1%. Among the total phenols, the content of chlorogenic acid is 0.4±0.015%, the mass ratio of chlorogenic acid, caffeic acid and p-coumaric acid is 35:15:6; the content of phenylethanol glycoside is 71.5±1.9%, and verbascoside The content is 85.7±2.3%.
实施例3、Embodiment 3,
将约20-40目桂花粉末加入于智能微波消解仪的聚四氟乙烯材料制成的内杯中,提取剂选用80%丙酮,料液比1:35(g/ml),控制压力300KPa,80W 微波处理 8min,过滤,再重复提取2次(即,以滤渣替代桂花粉末,依次重复上述微波处理和过滤2次),合并3次提取所得的滤液,滤液45℃真空旋转蒸发浓缩,浓缩液经-80℃预冻后真空冷冻干燥至恒重,得桂花多酚提取物,得率为25.1%。Add about 20-40 mesh sweet-scented osmanthus powder into the inner cup made of polytetrafluoroethylene material of the intelligent microwave digestion instrument. The extractant is 80% acetone, the ratio of solid to liquid is 1:35 (g/ml), and the control pressure is 300KPa. 80W microwave treatment for 8min, filter, and then repeat the extraction 2 times (that is, replace the osmanthus powder with filter residue, repeat the above microwave treatment and filtration 2 times in turn), combine the filtrate obtained from the 3 extractions, and concentrate the filtrate by vacuum rotary evaporation at 45°C, the concentrated solution After pre-freezing at -80°C, vacuum freeze-dry to constant weight to obtain osmanthus polyphenols extract with a yield of 25.1%.
对提取物进行成分测定及分析,该提取物含有绿原酸、咖啡酸、对香豆酸和毛蕊花苷。比色法与HPLC法分析桂花多酚提取物的成分含量,其总酚含量为60.8±2.1%。总酚中,绿原酸含量为0.4±0.01%,绿原酸、咖啡酸及对香豆酸质量比为40:15:7;苯乙醇苷含量为61.6±0.9%,苯乙醇苷中毛蕊花苷含量为87.1±2.5%。Composition determination and analysis were carried out on the extract, which contained chlorogenic acid, caffeic acid, p-coumaric acid and verbascoside. Colorimetric method and HPLC method were used to analyze the composition content of osmanthus fragrans polyphenols extract, and the total phenol content was 60.8±2.1%. Among the total phenols, the content of chlorogenic acid is 0.4±0.01%, the mass ratio of chlorogenic acid, caffeic acid and p-coumaric acid is 40:15:7; the content of phenylethanol glycoside is 61.6±0.9%, and verbascoside in phenylethanol glycoside The content is 87.1±2.5%.
实施例4、Embodiment 4,
将约20-40目桂花粉末加入于智能微波消解仪的聚四氟乙烯材料制成的内杯中,提取剂选用80%丙酮,料液比1:40(g/ml),控制压力400KPa,100W 微波处理 8min,过滤,再重复提取2次(即,以滤渣替代桂花粉末,依次重复上述微波处理和过滤2次),合并3次提取所得的滤液,滤液45℃真空旋转蒸发浓缩,浓缩液经-80℃预冻后真空冷冻干燥至恒重,得桂花多酚提取物,得率为28.0%。Add about 20-40 mesh sweet-scented osmanthus powder into the inner cup made of polytetrafluoroethylene material of the intelligent microwave digestion instrument. The extractant is 80% acetone, the ratio of solid to liquid is 1:40 (g/ml), and the control pressure is 400KPa. Microwave treatment at 100W for 8 minutes, filter, and repeat the extraction twice (that is, replace the osmanthus powder with filter residue, repeat the above microwave treatment and filtration twice in turn), combine the filtrate obtained from the three extractions, and concentrate the filtrate by vacuum rotary evaporation at 45°C. After pre-freezing at -80 ℃, vacuum freeze-drying to constant weight, the polyphenol extract of osmanthus fragrans was obtained, with a yield of 28.0%.
对提取物进行成分测定及分析,该提取物含有绿原酸、咖啡酸、对香豆酸和毛蕊花苷。比色法与HPLC法分析桂花多酚提取物的成分含量,其总酚含量为51.5±1.3%。总酚中,绿原酸含量为0.8±0.01%,绿原酸、咖啡酸及对香豆酸质量比为45:12:6;苯乙醇苷含量为68.8±1.7%,苯乙醇苷中毛蕊花苷含量为88.5±2.1%。Composition determination and analysis were carried out on the extract, which contained chlorogenic acid, caffeic acid, p-coumaric acid and verbascoside. Colorimetric method and HPLC method were used to analyze the composition content of osmanthus fragrans polyphenols extract, and the total phenol content was 51.5±1.3%. Among the total phenols, the content of chlorogenic acid is 0.8±0.01%, and the mass ratio of chlorogenic acid, caffeic acid and p-coumaric acid is 45:12:6; the content of phenylethanol glycoside is 68.8±1.7%, and verbascoside in phenylethanol glycoside The content is 88.5±2.1%.
实施例5Example 5
将约20-40目桂花粉末加入于智能微波消解仪的聚四氟乙烯材料制成的内杯中,提取剂选用80%丙酮,料液比1:45(g/ml),控制压力300KPa,100W 微波处理 3min,过滤,再重复提取2次(即,以滤渣替代桂花粉末,依次重复上述微波处理和过滤2次),合并3次提取所得的滤液,滤液45℃真空旋转蒸发浓缩,浓缩液经-80℃预冻后真空冷冻干燥至恒重,得桂花多酚提取物,得率为30.4%。Add about 20-40 mesh sweet-scented osmanthus powder into the inner cup made of polytetrafluoroethylene material of the intelligent microwave digestion instrument. The extractant is 80% acetone, the ratio of solid to liquid is 1:45 (g/ml), and the control pressure is 300KPa. Microwave treatment at 100W for 3 minutes, filter, and repeat the extraction twice (that is, replace the osmanthus powder with the filter residue, repeat the above microwave treatment and filtration twice in turn), combine the filtrate obtained from the three extractions, and concentrate the filtrate by vacuum rotary evaporation at 45°C. After pre-freezing at -80°C, vacuum freeze-dry to constant weight to obtain the polyphenol extract of sweet-scented osmanthus with a yield of 30.4%.
对提取物进行成分测定及分析,该提取物含有绿原酸、咖啡酸、对香豆酸和毛蕊花苷。比色法与HPLC法分析桂花多酚提取物的成分含量,其总酚含量为63.6±3.2%。总酚中,绿原酸含量为0.25±0.01%,绿原酸、咖啡酸及对香豆酸质量比为50:15:10;苯乙醇苷含量为60.1±1.5%,苯乙醇苷中毛蕊花苷含量为89.3±1.3%。Composition determination and analysis were carried out on the extract, which contained chlorogenic acid, caffeic acid, p-coumaric acid and verbascoside. The colorimetric method and HPLC method were used to analyze the composition content of the polyphenol extract of osmanthus fragrans, and the total phenol content was 63.6±3.2%. Among the total phenols, the content of chlorogenic acid is 0.25±0.01%, the mass ratio of chlorogenic acid, caffeic acid and p-coumaric acid is 50:15:10; the content of phenylethanol glycoside is 60.1±1.5%, and verbascoside in phenylethanol glycoside The content is 89.3±1.3%.
该实施例5所得总酚含量最高,达到桂花干花的19.3%。The obtained total phenolic content of this embodiment 5 is the highest, reaching 19.3% of the dried sweet-scented osmanthus.
为了充分证明本发明的技术优势所在,发明人还进行了如下的对比例:In order to fully prove the technical advantages of the present invention, the inventor has also carried out the following comparative examples:
比例1-1~1-对比例1-4、仅仅将提取剂由80%丙酮分别改成60%丙酮、100%丙酮、80%甲醇、80%乙醇;其余均等同于实施例5。Ratio 1-1~1-Comparative example 1-4, only change the extractant from 80% acetone to 60% acetone, 100% acetone, 80% methanol, and 80% ethanol; the rest are the same as in Example 5.
对提取物进行成分测定及分析,该提取物含有绿原酸、咖啡酸、对香豆酸和毛蕊花苷。具体含量如表2所述。Composition determination and analysis were carried out on the extract, which contained chlorogenic acid, caffeic acid, p-coumaric acid and verbascoside. The specific content is as described in Table 2.
表2Table 2
比例2-1、将控制压力300KPa、100W 微波处理 3min改成“控制压力200KPa、100W 微波处理 3min”,其余均等同于实施例5。Proportion 2-1. Change the control pressure 300KPa, 100W microwave treatment for 3 minutes to "control pressure 200KPa, 100W microwave treatment for 3 minutes", and the rest are the same as in Example 5.
比例2-2、将控制压力300KPa、100W 微波处理 3min改成“控制压力500KPa、100W 微波处理 3min”,其余均等同于实施例5。Proportion 2-2, change the control pressure 300KPa, 100W microwave treatment for 3 minutes to "control pressure 500KPa, 100W microwave treatment for 3 minutes", and the rest are the same as in Example 5.
比例2-3、将控制压力300KPa、100W 微波处理 3min改成“控制压力300KPa、200W 微波处理 3min”,其余均等同于实施例5。For ratio 2-3, change the control pressure 300KPa, 100W microwave treatment for 3 minutes to "control pressure 300KPa, 200W microwave treatment for 3 minutes", and the rest are the same as in Example 5.
比例2-4、将控制压力300KPa、100W 微波处理 3min改成“控制压力300KPa、80W 微波处理 20min”,其余均等同于实施例5。For ratio 2-4, change the control pressure 300KPa, 100W microwave treatment for 3 minutes to "control pressure 300KPa, 80W microwave treatment for 20 minutes", and the rest are the same as in Example 5.
对比例2-5、将料液比由1:45(g/ml)改成1:20(g/ml),其余均等同于实施例5。Comparative example 2-5, change the ratio of solid to liquid from 1:45 (g/ml) to 1:20 (g/ml), and the rest are the same as in Example 5.
对比例2-6、将料液比由1:45(g/ml)改成1:60(g/ml),其余均等同于实施例5。Comparative example 2-6, change the ratio of solid to liquid from 1:45 (g/ml) to 1:60 (g/ml), and the rest are the same as Example 5.
将对比例2-1~对比例2-6所得的提取物进行成分测定及分析,该提取物中均含有绿原酸、咖啡酸、对香豆酸和毛蕊花苷。具体含量如表3所述。The extracts obtained in Comparative Examples 2-1 to 2-6 were subjected to component determination and analysis, and the extracts all contained chlorogenic acid, caffeic acid, p-coumaric acid and verbascoside. The specific content is as described in Table 3.
表3table 3
实验1、桂花多酚提取物对肿瘤细胞增殖的抑制作用Experiment 1. Inhibitory effect of osmanthus polyphenols extract on tumor cell proliferation
①细胞株及培养条件① Cell lines and culture conditions
人乳腺癌细胞 (MCF-7、MDA),人前列腺癌细胞(PC-3、LN-CaP),培养基为RPMI-1640,含10%灭活胎牛血清,5%二氧化碳孵箱中37℃培养。Human breast cancer cells (MCF-7, MDA), human prostate cancer cells (PC-3, LN-CaP), culture medium is RPMI-1640, containing 10% inactivated fetal bovine serum, 5% carbon dioxide incubator at 37℃ nourish.
②MTT比色法检测细胞增殖率② MTT colorimetric method to detect cell proliferation rate
收集对数期细胞,调整细胞悬液浓度为50000个/ml,每孔加入100ul细胞悬液,细胞放入培养箱培养,待贴壁后第二天给药,细胞放入培养箱培养24h。药物作用结束后,每孔加入20ulMTT(5mg/ml),培养3-4h,终止培养,小心吸去孔内培养液。每孔加入150ulDMSO,37℃温箱孵育10分钟或摇床低速振荡10分钟。后用酶标仪检测490nm各孔的吸光度(A)值记录结果,以时间为横坐标,吸光值为纵坐标绘制细胞生长曲线。按下式计算药物对细胞增殖的抑制率(IR)。 IR=[1-(用药组测定的平均A值/对照孔测定的平均A值)]×100%,并通过SPSSl7.0软件进行回归分析,计算IC50值(半致死抑制浓度),对桂花多酚提取物进行评价。Collect the logarithmic phase cells, adjust the concentration of the cell suspension to 50,000 cells/ml, add 100ul of the cell suspension to each well, put the cells into an incubator for culture, and administer the drug the next day after attaching to the wall, and put the cells into the incubator for 24 hours. After the drug effect is over, add 20ul MTT (5mg/ml) to each well, incubate for 3-4h, terminate the culture, and carefully suck off the culture medium in the well. Add 150ulDMSO to each well, incubate at 37°C for 10 minutes or shake at low speed on a shaker for 10 minutes. Then use a microplate reader to detect the absorbance (A) value of each hole at 490nm and record the results. The cell growth curve is drawn with the time as the abscissa and the absorbance value as the ordinate. The inhibitory rate (IR) of the drug on cell proliferation was calculated according to the formula. IR=[1-(the mean A value that medication group measures/the mean A value that control hole measures)] * 100%, and carry out regression analysis by SPSS17.0 software, calculate IC50 value (half-lethal inhibitory concentration), to sweet-scented osmanthus Polyphenol extracts were evaluated.
表4、各实施例和对比例中的桂花多酚提取物对各肿瘤细胞的IC50值The sweet-scented osmanthus polyphenol extract in table 4, each embodiment and comparative example is to each tumor cell IC 50 value
实验2、桂花多酚提取物对5α-还原酶活性的抑制作用Experiment 2. Inhibitory effect of osmanthus polyphenols extract on 5α-reductase activity
①大鼠5α-还原酶的制备① Preparation of rat 5α-reductase
取清洁级雌性SD大鼠3只,禁食不禁水过夜后脱颈椎处死,取出肝脏冰台上剪碎。用预冷的缓冲液在玻璃匀浆器制成1:5匀浆,在4 ℃下,10000 g离心力下离心15 min,取胞浆部分100000 g离心力下离心1 h,倒掉上清,沉淀即为粗微粒提取物。加入一定体积缓冲液,并用匀浆器进行匀浆悬浮。分装,-80℃冰箱保存。Three clean-grade female SD rats were taken, fasted without food and water overnight, and then killed by dislocation of the cervical vertebrae. The liver was taken out and cut into pieces on ice. Use the pre-cooled buffer solution to make a 1:5 homogenate in a glass homogenizer, centrifuge at 10,000 g for 15 min at 4 °C, take the cytoplasmic part and centrifuge for 1 h at 100,000 g, discard the supernatant, and precipitate It is the coarse particle extract. Add a certain volume of buffer, and use a homogenizer to homogenate the suspension. Aliquot and store in -80°C refrigerator.
② 5α-还原酶的活性测定② Determination of 5α-reductase activity
a. 5α-还原酶的活性测定体系:0.5mL 20μM磷酸缓冲液(pH=6.5),0.1 mL50%乙醇(反应管)或样品溶液(样品管),150μL 0.5mg/mL睾酮,250μL 0.8mg/mL NADPH,添加0.5mL 浓度依次为0、0.96、1.92、2.88、3.84、4.80mg/mL酶提取物。在37℃下反应30分钟后,加入2.5mL二氯甲烷使反应停止,然后加入0.25mL的100μg/mL丙基羟苯酸酯作为内标,摇晃60s,在400g离心力下离心10min。a. 5α-reductase activity assay system: 0.5mL 20μM phosphate buffer (pH=6.5), 0.1mL 50% ethanol (reaction tube) or sample solution (sample tube), 150μL 0.5mg/mL testosterone, 250μL 0.8mg/mL mL NADPH, add 0.5mL enzyme extract with concentrations of 0, 0.96, 1.92, 2.88, 3.84, 4.80mg/mL. After reacting at 37°C for 30 minutes, 2.5 mL of dichloromethane was added to stop the reaction, and then 0.25 mL of 100 μg/mL propylparaben was added as an internal standard, shaken for 60 s, and centrifuged at 400 g for 10 min.
b. HPLC测定酶活性:移出约1ml有机相并蒸干,残留物溶于1.5ml甲醇,取10μL高效液相进样测定残留睾酮与内标峰面积的比值并记为r反应,r反应值低说明酶活性高。色谱条件:luna C18(2)柱(4.6×250mm, 5μm);柱温:40℃;进样量:10μL;流速:1mL/min;流动相:65%甲醇,检测波长:242nm。b. Determination of enzyme activity by HPLC: remove about 1ml of organic phase and evaporate to dryness, dissolve the residue in 1.5ml of methanol, take 10μL of high performance liquid phase injection to measure the ratio of residual testosterone to internal standard peak area and record it as r reaction, r reaction value Low indicates high enzyme activity. Chromatographic conditions: luna C18 (2) column (4.6×250mm, 5μm); column temperature: 40°C; injection volume: 10μL; flow rate: 1mL/min; mobile phase: 65% methanol, detection wavelength: 242nm.
样品对5α-还原酶抑制率=(r样品-r反应)/(r空白-r反应)×100%;Inhibition rate of sample to 5α-reductase = (r sample - r reaction ) / (r blank - r reaction ) × 100%;
注:r空白---反应启动前加入二氯甲烷使得酶失活,测定酶空白管值;Note: r blank --- add dichloromethane before the reaction starts to inactivate the enzyme, and measure the value of the enzyme blank tube;
c. 相同的方法以非那雄胺为对照进行试验,计算桂花多酚提取物的非那雄胺当量。c. The same method was used to test finasteride as a control, and the finasteride equivalent of osmanthus polyphenols extract was calculated.
表5、各实施例和对比例中的桂花多酚提取物对5α-还原酶抑制作用Osmanthus fragrans polyphenols extract in table 5, each embodiment and comparative example is to 5α-reductase inhibition
最后,还需要注意的是,以上列举的仅是本发明的若干个具体实施例。显然,本发明不限于以上实施例,还可以有许多变形。本领域的普通技术人员能从本发明公开的内容直接导出或联想到的所有变形,均应认为是本发明的保护范围。Finally, it should be noted that the above examples are only some specific embodiments of the present invention. Obviously, the present invention is not limited to the above embodiments, and many variations are possible. All deformations that can be directly derived or associated by those skilled in the art from the content disclosed in the present invention should be considered as the protection scope of the present invention.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310169455.1A CN103223018B (en) | 2013-05-08 | 2013-05-08 | Flos Osmanthi Fragrantis polyphenol extract and its production and use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310169455.1A CN103223018B (en) | 2013-05-08 | 2013-05-08 | Flos Osmanthi Fragrantis polyphenol extract and its production and use |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410330980.1A Division CN104147139A (en) | 2013-05-08 | 2013-05-08 | Application of sweet-scented osmanthus polyphenol extract |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103223018A CN103223018A (en) | 2013-07-31 |
CN103223018B true CN103223018B (en) | 2015-09-30 |
Family
ID=48833814
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310169455.1A Active CN103223018B (en) | 2013-05-08 | 2013-05-08 | Flos Osmanthi Fragrantis polyphenol extract and its production and use |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103223018B (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101595987B1 (en) * | 2013-12-26 | 2016-02-19 | 동의대학교 산학협력단 | A composition comprising Osmanthus matsumuranus extracts having anti-cancer activity |
CN103768151B (en) * | 2014-01-29 | 2016-03-16 | 浙江大学 | Flos Osmanthi Fragrantis phenethyl alcohol glycoside extract is preparing the application in antiaging agent or health product |
CN103768152B (en) * | 2014-01-29 | 2016-03-16 | 浙江大学 | Flos Osmanthi Fragrantis phenethyl alcohol glycoside extract and its production and use |
CN104231011B (en) * | 2014-09-12 | 2017-02-15 | 苏州禾研生物技术有限公司 | Preparation method of verbascoside |
CN104970418A (en) * | 2015-07-20 | 2015-10-14 | 南京飞马食品有限公司 | Production method for biological osmanthus by complex enzyme method |
CN105832603A (en) * | 2016-04-22 | 2016-08-10 | 无限极(中国)有限公司 | Preparation method and application of sweet-scented osmanthus extract |
CN105832789A (en) * | 2016-05-16 | 2016-08-10 | 威海松龄诺可佳中药饮片股份有限公司 | Method for preparing saponin enriched product through high-pressure microwave assisted semi-bionic extraction |
CN106107285A (en) * | 2016-06-30 | 2016-11-16 | 三明市建宁县泓鑫食品有限公司 | A kind of production method of fresh lotus seed beverage |
CN107722085A (en) * | 2017-10-19 | 2018-02-23 | 湖北科技学院 | The Phenylethanoid glycosides extracted from sweet osmanthus and its application and extracting method |
CN108531543A (en) * | 2018-03-12 | 2018-09-14 | 黄健聪 | A kind of external combined method of evaluation hair tonic/Anti-hair loss effect |
CN112535650A (en) * | 2020-12-09 | 2021-03-23 | 重庆市药物种植研究所 | Method for extracting polyphenol substances from sweet osmanthus pericarp and application |
CN113024619B (en) * | 2021-03-12 | 2022-09-09 | 浙江省立同德医院 | A kind of Cinnamomum chinensis leaf residue extract after distillation, its extraction method and antitumor use |
CN117099889A (en) * | 2022-10-20 | 2023-11-24 | 湖北科技学院 | Beverage with osmanthus flavor and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1277209A (en) * | 2000-07-07 | 2000-12-20 | 刘征涛 | Microwave process of extracting polysaccharides and polyphenols from tea |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100779026B1 (en) * | 2006-05-16 | 2007-11-28 | 신일제약주식회사 | Gogol extract useful for treating and preventing inflammatory diseases |
TW200916110A (en) * | 2007-10-04 | 2009-04-16 | Univ Chung Hwa Med Technology | Method for extracting anti-asthma substance from Osmanthus fragrans flowers |
CN102085223A (en) * | 2009-12-08 | 2011-06-08 | 华中科技大学 | Sweet osmanthus flower extractive as well as preparation method and application thereof to liver protection |
JP2012193121A (en) * | 2011-03-15 | 2012-10-11 | Kose Corp | Matrix metalloproteinase activity inhibitor |
-
2013
- 2013-05-08 CN CN201310169455.1A patent/CN103223018B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1277209A (en) * | 2000-07-07 | 2000-12-20 | 刘征涛 | Microwave process of extracting polysaccharides and polyphenols from tea |
Non-Patent Citations (4)
Title |
---|
Antioxidant activity and melanogenesis inhibitory effect of the acetonic extract of Osmanthus fragrans: A potential natural and functional food flavor additive;Li-chen Wu et al.;《LWT – Food Science and Technology》;20091231;第42卷;第1513-1519页,尤其是第1514页右栏第2段,第1516页左栏第1段 * |
Christophe Wiart.9.2.3.1.9 Osmanthus fragrans (Thunb.) Lour.《Medicinal Plants of China, Korea, and Japan: Bioresources for Tomorrow’s Drugs and Cosmetics》.CRC Press,2012,第340-341页,尤其是第341页第1、2段. * |
Neuroprotection and free radical scavenging effects of Osmanthus fragrans;Hsin-Hsueh Lee et al.;《Journal of Biomedical Science》;20071231;第14卷;第819-827页,尤其是第820页右栏第3段,第823页右栏第2段、表1 * |
Phenolic Antioxidants Isolated from the Flowers of Osmanthus fragrans;Chien-Ya Hung et al.;《Molecules》;20120907;第17卷;第10724-10737页,尤其是第10725页第1段,第10732页最后1段 * |
Also Published As
Publication number | Publication date |
---|---|
CN103223018A (en) | 2013-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103223018B (en) | Flos Osmanthi Fragrantis polyphenol extract and its production and use | |
Kumarasamy et al. | Bioactivity of gentiopicroside from the aerial parts of Centaurium erythraea | |
KR20210038369A (en) | Detergent composition comprising oriental medical extract for preventing alopecia and promoting hair growth and method for producing the same | |
Hao-Cong et al. | Chemical constituents and pharmacologic actions of Cynomorium plants | |
KR102118433B1 (en) | Composition comprising extract of Anemone raddeana, Lonicera species and Aralia elata including high concentrated saponin of anticancer activity for preventing or treating cancer and producing method the same | |
CN103951645B (en) | The preparation method of Changbai larch extract and medicinal use | |
El-Hawary et al. | Phyto-and Bio-Chemical evaluation of Diospyros kaki L. cultivated in Egypt and its biological activities | |
CN105385747A (en) | Method for preparing phenolic acid compound through fatsia japonica | |
CN104147139A (en) | Application of sweet-scented osmanthus polyphenol extract | |
KR100982806B1 (en) | The manufacturing method of natural antifungal material for food from dioscoreaceae | |
CN114081178B (en) | Rosa roxburghii pomace combined phenol with remarkable antioxidant activity and preparation method and application thereof | |
US8470858B2 (en) | Agave syrup extract having anticancer activity | |
CN115414399A (en) | Application of traditional Chinese medicine composition in preparation of antitumor drugs | |
CN100427099C (en) | Juglans polysaccharide preparation capable of effectively treating brain cancer and preparation method thereof | |
KR102262317B1 (en) | Composition for anticancer or cancer supplement comprising root extract of Rhododendron mucronulatum | |
Alaboo et al. | Phytochemical, antioxidant and anti-cancer properties of Urtica dioica | |
KR101603490B1 (en) | - Method for Extration of -sitosterol from Plant Using Supercritical Fluid Extraction | |
CN101721434A (en) | Active ingredients of fomes officinalis, preparation method thereof and use thereof | |
CN103720740A (en) | Gynostemma pentaphylla extract and fungus transformation preparation method thereof | |
Luo et al. | Antioxidant Activity and Components of the Ethanol Extract of Sisal Waste | |
CN110623995A (en) | Extraction of total flavonoids from aerial part of licorice and preparation method of liposome | |
CN103181997A (en) | Method for processing bittersweet herb | |
Shanaida | Comparative analysis of phenolic compounds in the american basil and wild bergamot herbs | |
Ko et al. | Changes in ginsenoside composition of white ginseng by fermentation | |
RO138084A2 (en) | Process for preparing bioactive extracts and compounds with therapeutical properties from hedera helix l. leaves |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |